19.15

4.59% 0.84

After Hours: 19.12 -0.03 -0.16%

Corbus Pharmaceuticals Holdings Inc (CRBP)

Overview News Price History Financials Discussions Forecast Stock Split

Corbus Pharmaceuticals Holdings Inc stock is traded at $19.15, with a volume of 460.25K. It is up +4.59% in the last 24 hours and down -0.31% over the past month. Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Previous Close:

$18.31

Open:

$18.43

24h Volume:

460.25K

Relative Volume:

0.72

Market Cap:

$225.11M

Revenue:

$1.54M

Net Income/Loss:

$-34.97M

P/E Ratio:

-1.7409

EPS:

-11

Net Cash Flow:

$-30.09M

1W Performance:

+18.21%

1M Performance:

-0.31%

6M Performance:

-50.61%

1Y Performance:

+266.16%

1-Day Range:

$18.02

$19.50

1-Week Range:

$15.92

$19.50

52-Week Range:

$3.0334

$61.90

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile

Name

Corbus Pharmaceuticals Holdings Inc

Sector

Healthcare (1182)

Industry

Biotechnology (671)

Phone

617-963-0103

Address

500 RIVER RIDGE DRIVE, NORWOOD, MA

Employee

Twitter

@corbuspharma

Next Earnings Date

2024-11-05

Latest SEC Filings

CRBP's Discussions on Twitter

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-08-20	Downgrade	BTIG Research	Buy → Neutral
Sep-08-20	Downgrade	Jefferies	Buy → Hold
Sep-08-20	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Sep-08-20	Downgrade	ROTH Capital	Buy → Neutral
Jul-07-20	Initiated	ROTH Capital	Buy
Jun-17-20	Initiated	BTIG Research	Buy
Mar-26-20	Initiated	Nomura	Buy
Apr-05-19	Initiated	Jefferies	Buy
Mar-20-19	Initiated	Oppenheimer	Outperform
Jan-11-19	Reiterated	Cantor Fitzgerald	Overweight
Dec-26-18	Initiated	H.C. Wainwright	Buy
Dec-07-18	Initiated	RBC Capital Mkts	Outperform
Oct-24-18	Initiated	B. Riley FBR	Buy
Jan-19-18	Initiated	Raymond James	Outperform
Dec-14-17	Reiterated	Cantor Fitzgerald	Overweight
Nov-08-17	Reiterated	Noble Financial	Buy
Sep-29-17	Resumed	Noble Financial	Buy
Mar-30-17	Reiterated	Cantor Fitzgerald	Overweight
Nov-15-16	Reiterated	JMP Securities	Mkt Outperform
Nov-11-16	Reiterated	Noble Financial	Buy

View All

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Latest News

02:12 AM

Vanguard Group Inc's Strategic Acquisition in Corbus Pharmaceuti - GuruFocus.com

02:12 AM

Nov 04, 2024

Corbus Pharmaceuticals' (CRBP) Outperform Rating Reaffirmed at Wedbush - MarketBeat

Nov 04, 2024

Corbus Pharmaceuticals Presents New CRB-913 Pre-Clinical Data At Obesity Week 2024 - GlobeNewswire

Nov 04, 2024

Nov 01, 2024

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

Nov 01, 2024

Oct 31, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Oct 31, 2024

Short Interest in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Grows By 5.8% - MarketBeat

Oct 31, 2024

Oct 30, 2024

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives $65.86 Consensus Price Target from Brokerages - MarketBeat

Oct 30, 2024

Oct 29, 2024

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch

Oct 29, 2024

Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference - GlobeNewswire

Oct 29, 2024

Oct 28, 2024

Corbus Pharmaceuticals Holdings Inc. stock rises Monday, still underperforms market - MarketWatch

Oct 28, 2024

Oct 26, 2024

(CRBP) Investment Report - Stock Traders Daily

Oct 26, 2024

Oct 25, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch

Oct 25, 2024

Oct 24, 2024

Corbus Pharmaceuticals Holdings Inc. stock rises Thursday, still underperforms market - MarketWatch

Oct 24, 2024

Oct 23, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Oct 23, 2024

Oct 22, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Oct 22, 2024

Corbus Pharmaceuticals (NASDAQ:CRBP) Stock Price Crosses Below 50 Day Moving AverageWhat's Next? - MarketBeat

Oct 22, 2024

Oct 21, 2024

Oppenheimer maintains steady target on Corbus Pharmaceuticals By Investing.com - Investing.com UK

Oct 21, 2024

Oct 16, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch

Oct 16, 2024

Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (CRB-701) - GlobeNewswire

Oct 16, 2024

Oct 15, 2024

Millennium Management LLC Adjusts Stake in Corbus Pharmaceuticals - GuruFocus.com

Oct 15, 2024

Oct 14, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch

Oct 14, 2024

Oct 11, 2024

Octagon Capital Advisors LP Increases Stake in Corbus Pharmaceuticals Holdings Inc - GuruFocus.com

Oct 11, 2024

Short Interest in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Rises By 106.3% - MarketBeat

Oct 11, 2024

Short Interest in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Grows By 106.3% - MarketBeat

Oct 11, 2024

Oct 10, 2024

Buying Buzz: Corbus Pharmaceuticals Holdings Inc [CRBP] 10% Owner Cormorant Asset Management, LP purchases 350,000 shares of the company – Knox Daily - Knox Daily

Oct 10, 2024

Vertex Pharmaceuticals, Inc. [NASDAQ: VRTX] Sees Increase in Stock Value - Knox Daily

Oct 10, 2024

Stock Surge: Corbus Pharmaceuticals Holdings Inc (CRBP) Closes at 18.52, Marking a -5.41 Increase/Decrease - The Dwinnex

Oct 10, 2024

Corbus Pharmaceuticals Holdings Inc’s Shares Reel: -65.28% Quarterly Revenue Decline Amid 222.98M Market Cap - The InvestChronicle

Oct 10, 2024

Oct 08, 2024

Millennium Management LLC Sells 83,253 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - MarketBeat

Oct 08, 2024

Oct 05, 2024

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Average Rating of "Buy" from Analysts - MarketBeat

Oct 05, 2024

Oct 03, 2024

10% Owner Cormorant Asset Management, LP acquired 350,000 shares of Corbus Pharmaceuticals Holdings Inc [CRBP] – Knox Daily - Knox Daily

Oct 03, 2024

Is Corbus Pharmaceuticals Holdings, Inc. (CRBP) the Best Russell 2000 Stock to Buy According to Analysts? - Insider Monkey

Oct 03, 2024

Oct 02, 2024

Corbus Pharmaceuticals Holdings Inc’s Market Journey: Closing Weak at 19.23, Down -6.79 - The Dwinnex

Oct 02, 2024

Oct 01, 2024

Point72 Asset Management L.P. Reduces Stock Holdings in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Oct 01, 2024